Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. - Wikidata - wikimedia - TriplyDB

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

http://www.wikidata.org/entity/Q44643929

about

Hepatic steatosis: a benign disease or a silent killer Hepatitis C virus infection protein network Hepatitis C virus and type 2 diabetes NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations Hepatitis C Virus, Insulin Resistance, and Steatosis KASL clinical practice guidelines: management of hepatitis C Association between hepatitis B and metabolic syndrome: Current state of the art Hepatitis C and insulin action: An intimate relationship Steatosis and hepatitis C Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis Hepatitis C virus infection and type 1 and type 2 diabetes mellitus Review article: HCV genotype 3 – the new treatment challenge Metabolic factors and chronic hepatitis C: a complex interplay Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells The natural history of hepatitis C virus (HCV) infection.Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C Fatty liver in chronic hepatitis C infection: unravelling the mechanisms Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease Targeting host factors: A novel rationale for the management of hepatitis C virus Molecular mechanisms of insulin resistance in chronic hepatitis C Antiviral therapy in hepatitis C virus cirrhotic patients in compensated and decompensated condition Host Genetics, Steatosis and Insulin Resistance among African Americans and Caucasian Americans with Hepatitis C Virus Genotype-1 Infection Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4 Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Pioglitazone decreases hepatitis C viral load in overweight, treatment naïve, genotype 4 infected-patients: a pilot study Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C Diagnosis, management, and treatment of hepatitis C: an update Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies Identification of liver fibrosis in HIV/HCV-coinfected patients using a simple predictive model based on routine laboratory data.An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.Individualisation of antiviral therapy for chronic hepatitis C.Community-based cross-sectional study: the association of lipids with hepatitis C seropositivity and diabetes mellitus.Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.Mechanisms and significance of liver steatosis in hepatitis C virus infection

P2860

Q22305506-ABFC5EE7-4551-47D1-8951-EC121A1091D7 Q24311906-1C1F9F47-1E56-4717-84F6-B2744499259B Q24658049-0E1EE993-3112-49A0-AD17-78B892C56404 Q26745576-7BFA4501-0C13-45A6-8CAB-A8EA08F574E4 Q26751755-AE542A69-1DD7-4DD8-A214-CB4A0FE907C5 Q26752471-4ECE0CE7-4C6F-4B07-8303-0C278D2C6656 Q26772343-1A250665-253A-40D2-B73F-17D16C8716C0 Q26775000-3A879F7E-736E-4AA7-B4F3-68AEC7F9CFA3 Q26798101-DE240534-49F9-4E27-B53B-532B3733B2E9 Q26823196-89F49A2F-56F1-4183-97FC-23A3C98C4678 Q26829202-4CBC0A51-AF1A-4978-AB7F-8FBB20BB7431 Q26864571-8DAAB4B1-7736-4278-8E78-C977E4BB89B3 Q27011787-1FE09F90-1076-4A93-8673-5E5829E1D844 Q27023059-2152CD15-0B1A-4A7E-8434-8D41BB244D47 Q27473116-DC660A0F-0725-4B64-B235-39609AFB838C Q27478305-EE92B603-6E30-4F59-833B-473EFA12F845 Q27481041-ADA60B5F-CF69-430E-815E-C9EBBB8A2154 Q27481042-BDE4FF30-3EA0-4A0C-9440-7C14E1BED499 Q27488999-EBB04BA9-7AC5-43CE-82A1-0E34CF7DA605 Q27489665-302D46B8-7A6F-4318-A73E-C25F3E5D91E0 Q27490340-4D67CB63-641C-45A6-BDF6-7765B81E82B6 Q27490790-463DAA5A-A87D-4DDF-AC62-BB26912BA24E Q27490866-CCCB5B71-1409-405B-8D1E-023DF35E6C5A Q28079826-B0417904-BA5B-4701-8AC4-D277732AE7DC Q28481414-395A44CC-DD2F-4D3B-B0E2-3AA546DB097F Q28533706-578DDB0E-6007-4B33-B598-4D3E88842B87 Q29619682-2FF7627F-B670-4B36-924B-13C683D62101 Q30369757-1E417C99-6E4B-46CD-8E8F-174995A338DB Q30468484-CA39282E-DE67-4DD9-8BD8-915B4586E714 Q30485410-E680A9D0-1710-4090-87C3-F1A04926A745 Q31139499-CBCB845F-15FD-436C-BDDC-2BB029BFDD3A Q33286330-A0284A5A-AE1F-4EC6-9E57-090A44A6EFD9 Q33350754-C034AA24-1EC8-498B-BBB5-9FC402F5EEF7 Q33390478-3E2C8E75-57A7-4AA5-A96A-CAE3D9E4FC70 Q33402027-0745B3E2-E34D-4DDF-8044-F3877B35F08C Q33731308-55BD5ED9-3F94-43F1-B432-D20E5D8B46D3 Q33798375-2724C067-B984-40CB-8375-96BB01A4D35D Q33812148-CAA3CF82-1F31-4504-80AA-0E9AC7B8F594 Q33844192-7F23CF64-7EC7-42F9-8D79-DA3D4F38429B Q33866272-AC441DBC-82B8-4A99-BEA3-9AD95CDB8951

P2860

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

http://www.wikidata.org/entity/Q44643929

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Insulin resistance impairs sus ...... chronic hepatitis C patients.

@en

Insulin resistance impairs sus ...... chronic hepatitis C patients.

@nl

type

label

Insulin resistance impairs sus ...... chronic hepatitis C patients.

@en

Insulin resistance impairs sus ...... chronic hepatitis C patients.

@nl

prefLabel

Insulin resistance impairs sus ...... chronic hepatitis C patients.

@en

Insulin resistance impairs sus ...... chronic hepatitis C patients.

@nl

P1433

Q44643929-8592C796-DFC0-4190-8FB6-5BA20981194A

P1476

Q44643929-A1394B6A-B6F5-4630-AE5F-616668AD423E

P2093

Q44643929-334278FA-1146-4E59-93C1-EDE3FB880709

Q44643929-342E86E1-CBDF-4A5E-9D61-D8A24F666E02

Q44643929-5DA42EAC-22EF-43E1-84ED-CBD22B921FAF

Q44643929-6137B23E-F4CE-43A5-834A-8E94163DAFB1

Q44643929-7284B296-5E9A-4498-9A88-7D764D1E81CF

Q44643929-87A0D39F-A6B0-4A02-9362-087BE80F6899

Q44643929-8F87220B-3050-45E7-8238-22A295BCA49F

Q44643929-9CBB38F5-50E8-4B51-A1CE-FD7B627A3578

Q44643929-C6799AF7-9775-4770-960D-D138BD442787

Q44643929-D6CD078A-55C0-4A96-B866-B57396E197FB

P304

Q44643929-0D74DA31-8899-4A75-AA51-2913B396AFAE

P31

Q44643929-2B78A11E-A03E-4AA1-8363-B8ECFE7C21EE

P356

Q44643929-D59E1C4A-8E3E-4887-B50D-2B075B727783

P407

Q44643929-A31ED5F8-8AD2-4DEF-B9DB-FBB29FC3BB9C

P433

Q44643929-8648CBB5-2C80-4FCF-88F7-1DCBD5FB85B4

P478

Q44643929-DA54AB51-443E-4A7C-B479-37DF5C069D82

P50

Q44643929-0BA16AFB-238E-40E0-ACD8-685256682BB1

Q44643929-3E699764-14D0-4CB8-86C3-1D0A961DECCA

Q44643929-3F89DA9A-30AF-4901-825E-64B8DF951317

Q44643929-7978F4CB-2315-4FB4-90D9-DAA2BA42D7AD

P577

Q44643929-D59C143E-F201-4793-9F3D-FEB212669BBD

P698

Q44643929-F6C8911E-B7B5-43D5-9AED-DA6E17E1347F

P921

Q44643929-AE137879-2BBB-4922-AFFE-3CDCEFE30DCD

P356

J.GASTRO.2004.12.049

P1433

Gastroenterology

P1476

Insulin resistance impairs sus ...... n chronic hepatitis C patients

@en

P2093

Ana Gila

http://www.w3.org/2001/XMLSchema#string

Celia Pérez

http://www.w3.org/2001/XMLSchema#string

Emilio Suárez

http://www.w3.org/2001/XMLSchema#string

Javier Salmerón

http://www.w3.org/2001/XMLSchema#string

Jesús Castillo

http://www.w3.org/2001/XMLSchema#string

Lourdes Grande

http://www.w3.org/2001/XMLSchema#string

Luis Vázquez

http://www.w3.org/2001/XMLSchema#string

Manuel Romero-Gómez

http://www.w3.org/2001/XMLSchema#string

Maria Del Mar Viloria

http://www.w3.org/2001/XMLSchema#string

Marina Cruz

http://www.w3.org/2001/XMLSchema#string

P304

636-641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2004.12.049

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Conrado M Fernandez Rodríguez

Raul J. Andrade

A Ruiz-Extremera

María-Luisa Gutiérrez

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15765399

http://www.w3.org/2001/XMLSchema#string

P921